DIVIS LABORATORIES
Back to All Ratios
|
DIVIS LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 97.85 | 74.64 | 81.77 | 123.26 | 84.38 |
What is the latest Cash Earnings per Share (CEPS) ratio of DIVIS LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 97.85 |
| Mar2024 | 74.64 |
| Mar2023 | 81.77 |
| Mar2022 | 123.26 |
| Mar2021 | 84.38 |
How is Cash Earnings per Share (CEPS) of DIVIS LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 97.85 | 31.10 | |
| Mar2024 | 74.64 | -8.72 | |
| Mar2023 | 81.77 | -33.66 | |
| Mar2022 | 123.26 | 46.08 | |
| Mar2021 | 84.38 | - | |
Other Financial Ratios of DIVIS LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹163,144.4 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
| MANKIND PHARMA | ₹82,617.3 Cr | -4.8% | 1% | -4.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.1% |
-0.2% |
7.4% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses